One Command Center.
A trillion possibilities for precision.

Our gut houses trillions of bacteria,70% of our immune cells, and 500 million neurons. This rich and diverse community of cells, otherwise known as the enteric signaling network, acts as a command center by transmitting information throughout the body that can affect our propensity for disease.

Learn More

Precision Enteric Medicines™ (PEM™) Platform

With over 44,000 genes and hundreds of metabolites newly discovered by Kintai scientists, our expertise in chemistry, human biology, experimental medicine and artificial intelligence fuel our PEM™ discovery platform to rapidly identify and develop new medicines.


Genetic

>44,000

Newly discovered genes

Biochemical

>19,000

GI tract localization of >19,000 protein families

Metabolite

>400

Previously uncharacterized compounds

PEM™ Platform

>10

Therapeutic programs


Learn More 

Robust and Diverse Pipeline

Through a multidisciplinary approach leveraging the interconnected biology of the microbiome, gut immune system, and enteric nervous system and their roles in human pathology, Kintai has an initial portfolio of more than 10 therapeutic programs targeting multiple indications, including autoimmunity, cancer and neurological disease.



autoimmunity


immunology graphic


cancer

oncology graphic


neurological

neurology graphic


Learn More

People Power

The company is deploying creative and bright minds from academia and industry to apply cutting edge experimental medicine approaches to expedite development and increase probability of success in bringing revolutionary medicines to patients. 

Learn More